0001415889-23-012152.txt : 20230811 0001415889-23-012152.hdr.sgml : 20230811 20230811173020 ACCESSION NUMBER: 0001415889-23-012152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDERSON A SCOTT CENTRAL INDEX KEY: 0001184825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18592 FILM NUMBER: 231165330 MAIL ADDRESS: STREET 1: ONE SOUTH MAIN, SUITE 1134 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000856982 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870447695 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 WEST MERIT PARK WAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 8012531600 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 4 1 form4-08112023_090814.xml X0508 4 2023-08-09 0000856982 MERIT MEDICAL SYSTEMS INC MMSI 0001184825 ANDERSON A SCOTT 1600 WEST MERIT PARKWAY SOUTH JORDAN UT 84095 true false false false 0 Common Stock, No Par Value 2023-08-09 4 M 0 25000 50.50 A 71397 D Common Stock, No Par Value 2023-08-09 4 S 0 22180 69.40 D 49217 D Non-qualified stock options (right to buy) 50.5 2023-08-09 4 M 0 25000 0 D 2019-06-07 2025-06-07 Common Stock 25000 0 D Non-qualified stock options (right to buy) 52.17 2020-05-24 2026-05-24 Common Stock 13750 13750 D Non-qualified stock options (right to buy) 52.17 2020-05-31 2026-05-31 Common Stock 7500 7500 D The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.91 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. /s/ Brian G. Lloyd, Attorney-in-Fact 2023-08-11